XRCC5 and breast carcinoma: The data revealed that XRCC5 rs16855458 was associated with increased breast cancer risk in the co‐dominant genetic model, and the CG + GG genotype of XRCC6 rs2267437 was associated with an increased risk of ER−/PR− breast cancer, even after Bonferroni correction.